Xcyte Therapies' Acquisition

Xcyte Therapies was acquired by Cyclacel Pharmaceuticals on March 14, 2006.

Xcyte Therapies, development stage biotechnology company, develops therapeutic products that enhance the body's natural immune responses to treat cancer, infectious diseases, and other medical conditi…

Articles about Xcyte Therapies' Acquisition: